Lymphoproliferative diseases (LPD) associated with primary immune disorders (PID)

A heterogeneous group of LPDs arise because of various PIDs, acting through various mechanisms, of which unrestrained infection with EBV is the most common. Diffuse large B-cell lymphoma is the most common lymphomas in the setting of PID.

 

abbreviation

aetiology of LPD

precursor lesions

type of LPD

 

ataxia telangestasia

AT

abnormal ATM gene leads to defects of DNA repair

 

DLBCL, Burkitt lymphoma, pre-T ALL/LBL, T-PLL, classical HD

Wiskott-Aldrich syndrome

WAS

Defects of T-cell, B-cells, neutrophils and macrophages

lymphoid hyperplasia, nodal plasmacytosis with monoclonal gammopathy

DLBCL, lymphomatoid granulomatosis, classical HD

common variable immunodeficiency

CVID

chronic antigenic stimulation leads to lymphoid hyperplasia

 

fatal infectious mononucleosis, DLBCL, rarely T-cell lymphoma

severe combined immunodeficiency

SCID

 

   

X-linked immunoproliferative disorder (Duncan syndrome)

XLP

 

 

fatal infectious mononucleosis, Burkitt lymphoma

Nijmegen breakage syndrome

NBS

defective DNA repair

 

DLBCL

hyper-IgM syndrome

 

mutation of CD40 affects T-cell/B-cell interactions and differentiation of class-switched plasma cells

extensive proliferation of IgM-plasma cells (may be fatal), lack of germinal centres.

 

autoimmune lymphoproliferative syndrome

ALPS

FAS gene mutation blocks apoptosis with resulting accumulation of lymphoid cells

lymphoid hyperplasia

benign proliferations of CD4-/CD8- ab T-cells, rarely T-cell lymphoma, classical HD, NLPHD

Job's syndrome

 

 

 

DLBCL

 

 

Immunohistochemistry

Most LPDs secondary to PID are of B-cell lineage. However, EBV may cause down-regulation of B-cell antigens. CD19, CD20 and CD79a may therefore be aberrantly negative in PID-associated B-cell LPDs. EBV also causes CD30 expression in many LPDs. LMP-1 is commonly expressed.

Differential diagnosis

Prognosis

Most LPDs associated with PIDs are aggressive.

References

World Health Organization Classification of Tumours, Tumours of the haematopoietic and lymphoid tissues, IARC Press 2001.

 

This page last revised 23.12.2002.

©SMUHT/PW Bishop